HighTower Advisors, LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q1 2021$249,000
-7.4%
15,100
+3.4%
0.00%0.0%
Q4 2020$269,000
+102.3%
14,605
+9.4%
0.00%0.0%
Q1 2020$133,00013,3490.00%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,922,008$29,415,00015.52%
Omega Fund Management, LLC 2,437,603$18,282,00013.56%
DAFNA Capital Management LLC 228,939$1,717,0000.85%
Baupost Group 6,491,287$47,136,0000.41%
Rock Springs Capital Management LP 1,009,179$7,569,0000.36%
Bain Capital Public Equity Management, LLC 416,670$3,125,0000.29%
Cormorant Asset Management, LP 454,550$3,409,0000.28%
SPHERA FUNDS MANAGEMENT LTD. 309,400$2,321,0000.26%
Artal Group S.A. 600,000$4,500,0000.17%
Perceptive Advisors 435,000$3,167,0000.12%
View complete list of TRANSLATE BIO INC shareholders